STOCK TITAN

Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will present at the Canaccord Genuity 42nd Annual Growth Conference from August 8-11, 2022. CEO Michael A. Carr and CFO Bill Koschak are scheduled to speak on August 11, 2022, at 1:00 p.m. ET. The presentation will be available via webcast at this link. Additionally, Calyxt management is open to 1:1 meetings with attendees, coordinating through event organizers or investors@calyxt.com.

Positive
  • None.
Negative
  • None.

ROSEVILLE, Minn., July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference taking place August 8-11, 2022.

The presentation details are as follows:

Date: Thursday, August 11, 2022
Presentation Time: 1:00 p.m. ET
Webcast: https://wsw.com/webcast/canaccord76/clxt/2481993

A webcast of the presentation will be available for viewing and replay on the Investors section of Calyxt's website at www.calyxt.com.

Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to the event organizers or investors@calyxt.com to schedule.

About Calyxt:

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.

PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.

Contacts:

Calyxt Media Contact:

Calyxt Investor Relations Contact:


David Rosen/ John Garabo/ Michael Barron

Argot Partners

(212) 600-1902

media@calyxt.com

 

Kimberly Minarovich/ Cameron Willis

Argot Partners

(212) 600-1902

investors@calyxt.com

 


 

Logo (PRNewsfoto/Calyxt, Inc.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/calyxt-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference-301594599.html

SOURCE Calyxt, Inc.

FAQ

When will Calyxt present at the Canaccord Genuity 42nd Annual Growth Conference?

Calyxt will present on August 11, 2022, at 1:00 p.m. ET.

Who will represent Calyxt at the Canaccord Genuity conference?

CEO Michael A. Carr and CFO Bill Koschak will represent Calyxt.

Where can I watch Calyxt's presentation from the Canaccord Genuity conference?

The presentation can be viewed via webcast at https://wsw.com/webcast/canaccord76/clxt/2481993.

How can I schedule a meeting with Calyxt management during the conference?

Attendees can reach out to the event organizers or email investors@calyxt.com to schedule a meeting.

What is the focus of Calyxt, Inc.?

Calyxt is focused on plant-based synthetic biology, leveraging its proprietary PlantSpring™ technology platform.

CLXT

:CLXT

CLXT Rankings

CLXT Latest News

CLXT Stock Data

31.33M